Pleural Effusion Treatment Market Size to Grow at a CAGR of 4.90% in the Forecast Period of 2023-2028

Pleural Effusion Treatment Market Size to Grow at a CAGR of 4.90% in the Forecast Period of 2023-2028

The ‘Global Pleural Effusion Treatment Market Share, Size, Price, Trends, Growth, Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global pleural effusion treatment market, assessing the market on the basis of its segments like disease type, treatment, end use, and major regions.

The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.

Pleural Effusion Treatment Market Size, Share, Trends, Industry Report, Key Player, Major Segments, and Forecast

The key highlights of the report include:

Market Overview (2018-2028)

• Forecast CAGR (2023-2028): 4.90%

The increasing prevalence of pulmonary conditions, lung tumours, and pulmonary embolisms, worsened by unhealthy lifestyles, increasing number of smokers, and lack of emphasis on proper nutrition, is driving the market growth for pleural effusion treatment. In addition, the increasing cases of cognitive heart failure and pneumonia are escalating hospitalisation rates which, in turn, are boosting the need for better healthcare infrastructure and treatment facilities. Hence, growing collaboration between private medical innovators and governments, aimed towards improving pleural effusion treatment in healthcare units are further bolstering the global pleural effusion treatment market.

Get a Free Sample Report with Table of Contents –

Increasing awareness pertaining to the efficient treatment procedures for pleural effusion, rising disposable income, and growing advancements in diagnosis and treatment procedures in hospitals and ambulatory surgical centres are the crucial market driving factors. Innovations and increasing reliability of pleural effusion treatment procedures involving effective equipment, such as chest tubes, which makes the need for repetition of pleural taps redundant, are improving the trust and patient preference towards pleural effusion treatment.

Further, enhancement in the pleurodesis and thoracentesis treatment facilities are expected to be the major market drivers leading to bolstered recovery of patients, which in turn is expected to favour the pleural effusion treatment market growth in the forecast period.

Pleural Effusion Treatment Industry Definition and Major Segments

Pleural effusion, also known as ‘water on the lungs’ is a medical condition in which excessive fluid gets accumulated outside the lungs between the layers of pleura. The pleura are crucial as they facilitate breathing in a body and fluid accumulation can cause difficulty in breathing, among other complications. Pleural effusion treatment includes surgery, drainage catheter placement, and pleurodesis.

Read Full Report with Table of Contents –

Based on disease type, the market is bifurcated into:

• Transudate Effusion
• Exudate Effusion

On the basis of treatment, the market is divided into:

• Tube Thoracostomy (Chest Tube)
• Pleurodesis
• Thoracentesis
• Pleural decortication
• Pleural drain
• Others

By end use, the market is segmented into:

• Hospitals
• Specialised Clinics
• Ambulatory Surgical Centres
• Others

On the basis of region, the market is categorised into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Pleural Effusion Treatment Market Trends

The key trends in the global pleural effusion treatment market include the growing research and development activities taking place in the healthcare and pharmaceutical sector across the emerging economies. Growing innovations and technical upgradations of the medical instruments and pleural effusion treatment capabilities by major market players are leading to more ease and efficiency in the treatment procedures, thereby, catalysing the market growth.

Lung infections are getting more prevalent among the young population due to sedentary lifestyles, poor nutrition, and increased inclination towards smoking and drugs. This factor is expected to escalate the pleural effusion cases in the forecast period.

In regional terms, North America holds a decent share in the pleural effusion treatment market, which is being driven by the rising cases of cancer, obesity, kidney failure, and leukaemia, among other chronic conditions. Advanced medical infrastructure across strong economies such as the United States is further fuelling the market growth in this region. Meanwhile, the Asia Pacific is expected to witness steady growth in the forecast period due to the growing geriatric population leading to a greater number of cardiovascular and pulmonary conditions.

Key Market Players

The major players in the global pleural effusion treatment market report are

• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Biometrix
• Rocket Medical plc
• ICU Medical Inc.
• Others

The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

Read More Reports:

Brazil Waterproofing Market:

Global Cancer Screening Market:

Global Network Security Market:

Fleet Management Market:

South Korea Anxiety Disorder and Depression Market:

About Us:

Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.

EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.

Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.

Media Contact:

Company Name: Claight Corporation
Contact Person: Alex Parker, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA


Leave a Reply

Your email address will not be published. Required fields are marked *